Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values
Year: 2022
Type: article
Study design: Observational Study
Source: Bone
Institutions: Hanusch Hospital, Ludwig Boltzmann Institute of Osteology, Allgemeine Unfallversicherungsanstalt, Columbia University Irving Medical Center, Columbia University, Charles University, Institute of Rheumatology, Eli Lilly (United States), University of Oslo, SpesialistSenteret Pilestredet Park, New York State Department of Health, Helen Hayes Hospital
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4283801644
